After working for more than a year to gain investigational status of mifepristone in Canada, Dr. Ellen Wiebe of Vancouver has finally been approved to begin Canada’s first clinical trial of mifepristone. The study will be conducted at four research centers in Vancouver, Toronto, Quebec City and Sherbrooke despite continued problems getting proper funding. Mifepristone has not yet received general approval for use in Canada but has been given “investigational status” for Dr. Wiebe’s study. The FDA is currently considering mifepristone for approval in the United States, with final action expected by September 30, 2000. Click here to find out more about possible restrictions on the use of mifepristone in the United States.